Viewing nowGlupa Tablet 500mg (Metformin Hydrochloride)
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Darim Biotech Co., Ltd.

MFDS item code 200301119 · Notified 2003.03.14 · Insurance code 664600050
Treatment of type 2 diabetes mellitus
This medication helps patients with type 2 diabetes who struggle to control blood sugar levels with diet and exercise alone. It is particularly effective in overweight adult patients and can be used alone or in combination with other oral hypoglycemic agents or insulin therapy. Additionally, it can be used alone or together with insulin in children and adolescents aged 10 years and older, making it applicable to a wide age range. This medication improves blood sugar levels and aids in diabetes management, contributing to the maintenance of the patient's health.
The dose should be determined individually based on efficacy and tolerability and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose needed for adequate glycemic control, this medicine must be initiated at a low dose. Take 500mg per dose 2~3 times daily with meals. Increase the dose gradually by 500mg each week; doses up to 2000mg are usually divided into 2 doses daily, in the morning and evening. For doses exceeding 2000mg, administer in 3 divided doses with meals, up to a maximum of 2550mg daily. At initiation and during dose adjustment, measure fasting blood glucose to assess the response to treatment with this medicine and identify the minimum effective dose. Measure glycated hemoglobin levels approximately every 3 months. The goal of treatment with this medicine, administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In patients whose blood glucose was previously controlled by diet alone but is temporarily uncontrolled, short-term administration of this medicine may be sufficient to achieve an adequate effect. This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, using the following dose adjustments. - The initial dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be carefully monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, this medicine must be discontinued immediately.
Children aged 10 years and older or adolescents who are still growing: The usual initial dose is 500 milligrams once daily, administered during or after a meal. Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg, administered in 2~3 divided doses.
This medication can cause severe lactic acidosis or hypoglycemia, so caution is advised. Patients with moderate or severe renal impairment, dehydration, serious infections, cardiovascular issues, etc., should not take this medication. Patients with acute heart failure or those scheduled to undergo examinations using iodinated radiocontrast agents should also avoid this medication. Patients who have had allergic reactions to this medication or biguanide drugs, type 1 diabetes patients, and those with diabetic ketoacidosis should not be treated with this medication. Patients with severe infections or serious trauma should discontinue this medication until they can orally ingest and their kidney function returns to normal. Patients scheduled for surgery should stop taking this medication 48 hours prior to the procedure and can resume only after confirming normal renal function. Caution is necessary for individuals with poor nutritional status, liver dysfunction, lung dysfunction, or excessive alcohol consumption. Irregular meals or intense exercise, as well as interactions with other medications, can increase the risk of lactic acidosis and hypoglycemia, so should be administered carefully. Lactic acidosis is rare but can be fatal; therefore, if symptoms such as fatigue, muscle pain, shortness of breath, or abdominal pain occur, immediate medical attention should be sought. Gastrointestinal disturbances are common at the start of treatment, and taking the medication with food or gradually increasing the dose can help reduce these symptoms. This medication is primarily excreted by the kidneys, so regular kidney function tests are required, and it should be discontinued if kidney function declines. Alcohol intake can affect the metabolism of lactic acid from this medication and may increase the risk of lactic acidosis, so it is advisable to avoid it. Vitamin B12 deficiency may occur; thus, regular blood tests are recommended. Limited reports exist regarding fetal effects during pregnancy; however, if there is a risk of placental insufficiency or preeclampsia, it should be avoided. If breastfeeding, careful consideration should be given as this medication can be excreted in breast milk regarding whether to continue breastfeeding or to discontinue medication. For the elderly, since kidney function decline is common, treatment should start with lower doses while monitoring kidney function regularly. In cases of overdose, blood dialysis can remove this medication; therefore, if overdose is suspected, immediate medical attention should be sought. This medication does not cause weight gain and may even cause weight loss in some patients. Keep out of reach of children and do not transfer to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, and it is safe to store it at room temperature between 1°C and 30°C. It is advisable to avoid direct sunlight and not to place it in areas that are too hot or cold.
White elongated film-coated tablet
For domestic use: 500 tablets/bottle, 100 tablets/bottle, 60 tablets/bottle; for export: 500 tablets/bottle, 60 tablets/bottle, 60 tablets (10 tablets/PTPX6)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMetformin Hydrochloride 500mg
Tablet · Prescription medication
Darim Biotech Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.